Read More Pharma Industry News How EMA’s support for EURneffy 1 mg could disrupt Europe’s pediatric epinephrine market EMA backs EURneffy 1 mg for pediatric anaphylaxis. Find out how ARS Pharmaceuticals and ALK-Abelló could reshape Europe’s allergy care landscape. bySoujanya RaviFebruary 5, 2026